Osaic Holdings
IRD

Osaic Holdings’s Opus Genetics IRD Stock Holding History

Osaic Holdings’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$57.1K Buy
13,900
+11,700
+532% +$54.6K ﹤0.01% 5380
2026
Q1 		$10K Sell
2,200
-11,700
-84% -$40.5K ﹤0.01% 6292
2025
Q4 		$27.9K Sell
13,900
-4
-0% -$8 ﹤0.01% 5633
2025
Q3 		$23.7K Buy
13,904
+4
+0% +$5 ﹤0.01% 5822
2025
Q2 		$13.1K Sell
13,900
-11,505
-45% -$10.7K ﹤0.01% 5993
2025
Q1 		$24.9K Buy
25,405
+11,505
+83% +$12.9K ﹤0.01% 5203
2024
Q4 		$16.5K Sell
13,900
-5
-0% -$6 ﹤0.01% 5471
2024
Q3 		$18.2K Sell
13,905
-7,650
-35% -$11.8K ﹤0.01% 5440
2024
Q2 		$33K Buy
21,555
+5,046
+31% +$8.72K ﹤0.01% 4996
2024
Q1 		$33.2K Sell
16,509
-800
-5% -$2.03K ﹤0.01% 5027
2023
Q4 		$52.1K Sell
17,309
-4,225
-20% -$12.5K ﹤0.01% 4879
2023
Q3 		$72.1K Sell
21,534
-11,235
-34% -$45.1K ﹤0.01% 4745
2023
Q2 		$142K Buy
32,769
+32,748
+155,943% +$155K ﹤0.01% 4167
2023
Q1 		$79 Sell
21
-3,500
-99% -$12.6K ﹤0.01% 7351
2022
Q4 		$12K Buy
3,521
+3,473
+7,235% +$9.14K ﹤0.01% 5863
2022
Q3 		$0 Sell
48
-8,723
-99% -$18.8K ﹤0.01% 7556
2022
Q2 		$17K Buy
8,771
+8,750
+41,667% +$19.9K ﹤0.01% 5738
2022
Q1 		$0 Sell
21
-4,500
-100% -$15.4K ﹤0.01% 7554
2021
Q4 		$17K Buy
4,521
+4,100
+974% +$16.4K ﹤0.01% 5917
2021
Q3 		$2K Buy
421
+400
+1,905% +$1.84K ﹤0.01% 6902
2021
Q2 		$0 Hold
21
– – ﹤0.01% 7158
2021
Q1 		$0 Buy
21
+4
+24% +$37 ﹤0.01% 6975
2020
Q4 		$0 Sell
17
-1
-6% -$7 ﹤0.01% 6613
2020
Q3 		$0 Hold
18
– – ﹤0.01% 6449
2020
Q2 		$0 Hold
18
– – ﹤0.01% 6376
2020
Q1 		$0 Buy
+18
New +$156 ﹤0.01% 6213

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Osaic Holdings's IRD Position: Q2 2026 in Review

Osaic Holdings increased its Opus Genetics (IRD) stake by 532% in Q2 2026, buying an estimated $54.6K and bringing the position to 13,900 shares worth $57.1K. The position accounts for ﹤0.01% of the portfolio, ranked #5380.

Osaic Holdings first reported a position in IRD in Q1 2020 and has held it in 26 quarters since. The position peaked at $142K in Q2 2023. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Osaic Holdings held 13,900 shares of Opus Genetics worth $57.1K as of Q2 2026.
  • Osaic Holdings bought 11,700 Opus Genetics shares in Q2 2026, an estimated $54.6K.
  • Opus Genetics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #5380 holding.
  • Osaic Holdings first reported a position in Opus Genetics in Q1 2020 and has held it in 26 quarters since.
  • Osaic Holdings's Opus Genetics position peaked at $142K in Q2 2023.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.